LABCORP HOLDINGS INC. - Director's Dealing 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-11-01

Reporting Person: Kirchgraber Paul R (CEO, Covance Drug Development)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-01	Common Stock	M	2007	—	Acquired	9851	Direct
2021-11-01	Common Stock	F	898	$288.78	Disposed	8953	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-01	Restricted Stock Unit	$	M	2007	Disposed		Common Stock (2007)	Direct

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on November 1, 2020.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.